Page last updated: 2024-09-05

wy 41770 and Adjuvant Arthritis

wy 41770 has been researched along with Adjuvant Arthritis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carlson, RP; Chang, J; Datko, LJ; Lewis, AJ; Nielsen, ST1
Carlson, RP; Datko, LJ; Lewis, AJ; O'Neill-Davis, L1

Other Studies

2 other study(ies) available for wy 41770 and Adjuvant Arthritis

ArticleYear
The antiinflammatory profile of (5H-dibenzo[a,d]-cyclohepten-5-ylidene)acetic acid (WY-41,770), an agent possessing weak prostaglandin synthetase inhibitory activity that is devoid of gastric side effects.
    Agents and actions, 1984, Volume: 14, Issue:5-6

    Topics: Acetates; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Carrageenan; Cyclooxygenase Inhibitors; Dibenzocycloheptenes; Digestive System; Dinoprostone; Edema; Fever; Hyperesthesia; In Vitro Techniques; Irritants; Lipoxygenase Inhibitors; Macrophages; Male; Platelet Aggregation; Pleurisy; Prostaglandins; Prostaglandins E; Rats; Rats, Inbred Strains; Seminal Vesicles; Synovitis; Yeast, Dried

1984
Immunomodulating activity of Wy-41,770 (5H-dibenzo[A,D]cyclohepten-5-ylidene) acetic acid.
    Journal of immunopharmacology, 1986, Volume: 8, Issue:2

    Topics: Acetates; Animals; Arthritis, Experimental; Dibenzocycloheptenes; Encephalomyelitis, Autoimmune, Experimental; Erythrocytes; Guinea Pigs; Hypersensitivity, Delayed; Immune System; Immunoglobulin M; Indomethacin; Levamisole; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Inbred Lew

1986